Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
19.45
+0.15 (0.78%)
Dec 29, 2025, 1:37 PM EST - Market open
Nurix Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$27.46
Upside
+41.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $21 → $30 | Buy | Maintains | $21 → $30 | +54.24% | Dec 16, 2025 |
| Mizuho | Mizuho | Buy Maintains $24 → $30 | Buy | Maintains | $24 → $30 | +54.24% | Dec 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $31 | Strong Buy | Maintains | $28 → $31 | +59.38% | Dec 10, 2025 |
| BTIG | BTIG | Strong Buy Maintains $27 → $30 | Strong Buy | Maintains | $27 → $30 | +54.24% | Dec 9, 2025 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +33.68% | Dec 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $23 → $30 | Strong Buy | Initiates | $23 → $30 | +54.24% | Nov 24, 2025 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +33.68% | Nov 4, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +38.82% | Nov 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $28 | Strong Buy | Maintains | $33 → $28 | +43.96% | Oct 27, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $22 → $21 | Buy | Maintains | $22 → $21 | +7.97% | Oct 23, 2025 |
| BTIG | BTIG | Strong Buy Maintains $35 → $27 | Strong Buy | Maintains | $35 → $27 | +38.82% | Oct 23, 2025 |
| Needham | Needham | Strong Buy Maintains $27 → $26 | Strong Buy | Maintains | $27 → $26 | +33.68% | Oct 22, 2025 |
| Mizuho | Mizuho | Buy Initiates $24 | Buy | Initiates | $24 | +23.39% | Oct 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +69.67% | Oct 20, 2025 |
| Needham | Needham | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +38.82% | Oct 20, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | -22.88% | Oct 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.